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In the course of studying the recovery (1) of hemolytic plaque-forming cells 
in  the  spleen  of  lethally-irradiated thymectomized  mice,  we  observed  that 
allogeneic thymus grafts, unlike syngeneic ones, did not support this recovery. 
This  failure  was  contrary  to  expectations  based  on  published  experiments 
(2-5),  and  a  detailed investigation was therefore undertaken to  elucidate the 
question.  In particular, it seemed important to determine whether  the immu- 
nological deficiencies of the thymus-deprived animal could be divided into those 
restored by  thymus  homografts  and  those  not  restored by  this maneuver,  a 
finding which would support a dual mechanism of thymus action. Furthermore, 
such an investigation bears on the important and still unanswered question  of 
hurnoral vs. cellular means of thymus action. The  present experiments concern 
restoration of a variety of immune functions, both cellular  and humoral, in ir- 
radiated thymectomized mice grafted with  thymuses  from several  allogeneic 
strains. 
Materials  and  Methods 
AnimaL--Inbred  mice of various strains were  obtained from  the Jackson Laboratories, 
Bar Harbor, Maine, and during experiments  were maintained in an isolated caging system 
(Carworth Farms, New City, N. Y.) with acidified drinking water (addition of 5 ml of 12 N 
HC1 per 12 liters water to produce a pH of 2.5). Pregnant mice (12-14 days) were  obtained 
from the same laboratory. 
Experimental Design.--The details were similar to those in previous publications (1, 6, 7). 
Adtflt mice (female, 8-10 wk old) were thymectomized, lethally irradiated (875 R, 280 kv,  1.4 
mm Cu, 67 R/min), and injected intravenously with 4-5 million marrow cells obtained from 
the femurs of animals of the same strain and sex. Thymectomy was done within the week prior 
to irradiation, and marrow  grafting in the 4 hr after irradiation. Thymus grafting was per- 
formed with the technique  of East and Parrott (8); the day after irradiation a single whole 
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newborn (less than 36 hr old)  thymus was placed under the kidney capsule.  (In several ex- 
periments, mentioned separately in the text, the time of thymectomy or of thymus grafting 
was  delayed).  The usual  experiment contained 3  groups  of  16  animals,  irradiated control, 
thymectomy control, and  thymectomy with thymus graft.  Mortality for the experimental 
period was quite variable from experiment to experiment, and deaths tended to occur within 
particular isolated cages. Overall only about one-half the animals survived the entire experi- 
ment, but there was no excess mortality in any experimental group, and no disorder was seen 
that resembled the wasting disease of thymectomized newborns. Only data from surviving 
animals were employed. 
30 days after irradiation animals received full thickness skin grafts by conventional grafting 
technique (9). The plaster cast was removed on the 10th or llth day, and grafts were scored 
visually on alternate days for the next 2 wk and weekly thereafter. In those experiments in 
which the animals' spleens were plaqued, the skin graft could only be followed for 50 days, in 
those subject to graft vs. host assay for 100 days, and in the others for 140 days. Thus all im- 
munological parameters were not studied in a single experiment. All animals were subject to 
postmortem examination and animals with residual thymus were discarded from consideration. 
(However, it should be remarked that the thymus of normal CBA mice 140 days after lethal 
rrradiation may be a small unimpressive structure weighing only a few milligrams, and that 
therefore a  thymic remnant could be missed). Thymus grafts were examined and weighed at 
postmortem. 
Hemolytic Plaque Assay.--The method of Jerne et al.  (10)  as previously modified (6) was 
employed to determine the number of hemolysin-producing spleen cells.  Animals were chal- 
lenged with 0.2 ml of 10% sheep cells (5 X  l0  s cells) 75 days after irradiation, and were sacri- 
ficed 4 days later. An appropriate sample of sieved spleen was incubated with sheep erythro- 
cytes in Gey's solution which was gelled by the addition of Agarose. The gelled suspension was 
incubated for 2 hr at 37°C, 1 ml of 1 : 10 guinea pig serum was added, and the suspension incu- 
bated for an additional hr to develop the direct (19S) plaques. 
Graft-Vs.-Host Assay.--A published method was used (11). Newborn F1 mice of appropriate 
genotype (CBA X  DBA/2 or CBA X  A) were injected when less than 24 hr old. Sieved spleen 
cells (Medium 199) from three animals of each experimental group  (irradiation control,  thy- 
mectomy control, and thymectomy plus thymus graft) were pooled and injected intraperito- 
neally into appropriately marked newborns. Five to six newborns were employed to assay each 
spleen cell pool, and blank animals received only Medium 199. Animals were sacrificed 9 days 
after injection and spleen and body weight determined. 
Hemagglutir*ir~ and Hemolysin.--Animals  were challenged intravenously with 0.2 ml of 10% 
sheep cells and bled from a tall vein 7 days later. Sera were assayed with fresh sheep cells, with 
and without the addition of complement, employing the Microtiter apparatus and two-fold 
dilutions (12). 
Calculation of Per Cent Restoration of Graft Rejecticn.--Because of the large number of skin 
and thymus graft combinations employed, a simple calculation was devised to express restora- 
tion in each skin/thymus combination by a single per cent figure. Grafts rejected in less than 
17 days are assigued an arbitrary value of 1, those rejected in 17-25 days a value of 2, those 
rejected in 26-50 days a value of 3, and those surviving more than 50 days a Value of 4. (Where 
grafts are followed for 100 days, a value of 5 is assigned to each graft surviving more than 100 
days). The calculation is made separately for each skin/thymus combination by multiplying 
the number of animals whose grafts were rejected during a particular time period by the ap- 
propriate value and summing these products for each group (irradiated control, thymectomy 
control, and thymectomy with thymus graft)  in the particular combination. The sums are 
then corrected for the varying numbers of animals in each group: the sum for the irradiated 
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controls; the thymectomy graft sum is multiplied by the ratio of animals in that group to the 
number of thymectomy controls; the sum for the thymectomy control group remains unmodi- 
fied. The potential restoration of graft rejection is defined  as the sum for the thymectomy con- 
trol group minus the corrected  sum for the irradiation control group, and the observed  restora- 
tion for the graft defined as the sum for the thymectomy control group minus the corrected 
sum for the thymectomy thymus graft group. By dividing the figure for observed (thymus 
graft) restoration by the figure  for potential restoration and multiplying by 100, the resulting 
number is an estimate (in per cent) of restoration of that particular skin homograft rejection 
by that thymus graft. These calculations have been made for the data in Table I and the re- 
sults are presented in Table II. 
I~ESULTS 
Skin Grafting in CBA Mice.--Table I  presents data on skin homograft sur- 
vival in unoperated and control thymectomized CBA  mice,  and in  thymec- 
tomized animals bearing various thymus grafts under the kidney capsule. 
Without thymus grafting (Table I), the prolongation of skin graft survival in 
irradiated thymectomized CBA mice is quite variable. When the  incompati- 
bility lies outside the H-2 locus (AKR, C57BR/cd, and C3H) skin grafts are ac- 
cepted permanently, but with H-2 incompatibility this is not the case. The re- 
sults with DBA/2 skin are typical, with only 10 of 39 grafts retained beyond 
100 days and 4 grafts rejected normally. This great spread of rejection time is 
also  seen in  thymectomized CBA mice with  C57BL,  BALB/c, DBA/1,  and 
SJ-L skin. Strain A  skin is exceptional among the H-2 incompatible combina- 
tions,  and like  non-H-2  homografts,  it  is  permanently retained by thymec- 
tomized CBA mice. It is evident that A skin also enjoys a longer survival time 
in the intact controls than do the other H-2 incompatible skin grafts (14.2 days 
as compared with 11.5-12.6 days for the others). 
The data from Table I  on the restorative capacity of various thymus grafts 
on skin homograft rejection has been summarized in Table II.  Certain  con- 
clusions  are evident. Isogeneic thymus  (CBA)  completely restores skin graft 
rejection, and allogeneic H-2 compatible thymus (AKR) restores graft rejection 
even of skin with minor histocompatibility differences (with the exception of 
skin from the thymus donor). 
The results from grafting thymuses differing at the H-2 locus are more com- 
plex. C57BL thymus completely restores the rejection of skin from this strain, 
while A thymus similarly restores the rejection of A skin (Table II). Indeed, by 
examining the data in Table I  for mean rejection times, it is clear  that A  and 
C57BL thymus grafts lead to more rapid rejection of the respective skin than is 
seen in nonthymectomized controls. However, there appears to be only slight 
restoration of the rejection of third party homografts (13-17 %) with the excep- 
tion of DBA/2  and BALB/c (both H-2  b)  where animals  are restored to ap- 
proximately 75 % of normal. H-2 incompatible thymus homografts do not re- 
store  rejection  of  skin  differing at minor  (non-H-2)  histocompatibility loci 
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TABLE  I 
Skin and Thymus Grafting in Normal and Thymectomized CBA Mice 
Skin graft  Thymectomy  Thymus graft 
Number of mice with skin graft 
survival of 
<17  17-25  26-50  >50 or 
days  days  days  51-100  days  >100  days 
Average 
survival 
C57BL  --  -- 
C57BL  +  -- 
C57BL  +  A 
33  0  0  0 
4  12  5  10 
14  6  3  9 
12.1  ±  0.9 
A 
A 
A 
+ 
+  A 
27  0  0  0 
1  3  2  26 
20  1  2  3 
14.2  4-  0.7 
11.4"  4-  0.9 
C57BL  --  -- 
C57BL  +  -- 
C57BL  +  C57BL 
C57BL  -]-  AKR 
C57BL  +  CBA 
C57BL  Late:~  -- 
27  1  0  0 
1  4  10  20 
23  0  0  0 
16  1  0  0 
8  0  0  0 
1  4  5  2 
12.2  4-  0.6 
10.7  ±  1.3 
A 
A 
A 
+ 
+  C57BL 
28  0  0  0 
0  1  2  20 
3  0  2  15 
14.2  ±  1.6 
DBA/2  --  -- 
DBA/2  +  -- 
DBA/2  +  C57BL 
29  0  0  0  0 
4  6  11  8  10 
25  3  0  6  0 
12.6  -4-  1.4 
BALB/c  --  --  27  0  0  0 
BALB/c  +  --  5  5  4  20 
BALB/c  +  C57BL  32  4  3  3 
BALB/c  +  CBA  7  0  0  0 
11.8  +  1.9 
DBA/1  --  --  20  0  0  0 
DBA/1  +  --  1  2  3  11 
DBA/1  +  C57BL  1  5  5  7 
11.5  4-  1.0 
SJL  --  --  29  0  0  0 
SJL  +  --  5  3  9  7 
SJL  +  C57BL  11  3  6  10 
12.2  ±  1.6 
AKR  --  --  7  7  0  0  0 
AKR  +  --  0  0  0  0  16 
AKR  +  C57BL  0  0  0  0  5 
AKR  +  AKR  0  0  0  0  14 
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Skin graft  Thymectomy  Thymus graft 
Number of mice with skin graft 
survival of 
<17  17-25  26-50 >50 or  51-I00  >I00 
days  days  days  days  days 
Average 
survival 
AKR§  --  --  3  0  0  0  0 
AKR§  +  -  0  1  1  0  5 
AKR§  +  AKR  1  1  0  0  4 
C57BR/cd  --  --  3  5  1  0  0 
C57BR/cd  -b  -  1  0  0  1  10 
C57BR/cd  n  u  AKR  2  8  0  0  0 
C3H  --  --  0  6  3  0  0 
C3H  -}-  --  0  0  0  0  i0 
C3H  -~  AKR  1  7  1  1  0 
11.7 
19.1 
17.9 
24.4 
26.2 
* Average excludes 5 grafts rejected beyond 25 days. 
:~ Thymectomy delayed 14 days after irradiation and bone marrow grafting. 
§ Thymus grafting delayed 70 days after irradiation and bone marrow grafting. 
TABLE II 
Restoration* of Skin Graft Rejection by Thymus Grafting in CBA Mice (H--2  k) 
Strain of donor skin  H-2 
Strain of donor thymus 
C$TBL  A  AKR  CBA 
C57BL  b  101  27 
A  a  13  80 
DBA/2  d  74 
BALB/c  d  72 
DBA/1  q  17 
SJL  s  14 
AKR  k  0 
C57BR/cd  k 
C3H  k 
0 
106 
103 
99  101 
* Results expressed as the per cent of thymectomy impairment restored by thymus graft 
Derived from data in Table I  by calculations described in the text. 
Skin Grafting in C57BL Mice.--Lethal  irradiation and bone marrow grafting 
do not significantly delay rejection of H-2  incompatible homografts in the im- 
munologically more  reactive  C57BL  mouse  (Table  III).  To  demonstrate  sig- 
nificant prolongation  of homograft rejection in thymectomized animals  of this 
strain,  it is necessary  to graft  from strains  such  as the  129  (Table III)  which 
differs at a  locus other than the H-2. This markedly limits the studies that can 280  ALLOGENEIC  THYMUS GRAFTS 
be done in C57BL mice, and for this reason thymus grafting experiments were not 
undertaken  in  this  strain. 
Graft-Vs.-Host  Assays.--Graft-vs.-host  assays  are  consistent  with  the  skin 
graft  work  in  demonstrating  the  immunological  reactivity  of  thymectomized 
TABLE III 
Skin Grafting in Normal and Thymectomized C57BL Mice 
Number of mice with skin graft survival of 
Source of skin  Thymectomy  <17  17-25  26-50  51-100  >100  Average  survival 
days  days  days  day~  days 
C57BR/cd  --  7  0  0  0  0  12.0  ±  0.6 
+  4  1  0  0  0 
CBA  --  5  0  0  0  0 
+  5  0  0  0  0 
BALB/c  --  5  0  0  0  0 
+  5  0  0  0  0 
129/j  -  8  0  0  0  0  11.8  4-  0.6 
+  0  2  2  1  3 
TABLE IV 
Graft-Vs.-Host Assay* in Normal and Thymectomized CBA Mice with and without 
Thymus Grafts 
Source of spleen cells 
Assay strain 
Irradiated  Blank 
control 
DBA/2 X  CBA 
DBA/2 X  CBA 
A >(  CBA 
6.2  4-  2.0 
6.5  4-  1.1 
6.7  :t:  1.3 
*r  ....  I  Irradiated  [  Irradiated 
th~r~,reaca~a~ne~z ,~ [ thymectomized t thymeetomized 
,~  o  e_ ~  C57BLt  2ymus[ Athymus 
4.5  4-  1.1  6.0  4-  2.1 
4.8  4-  0.9  I  5.7  4-  2.2 
5.7  4-  0.8  [ 6.1  4-  0.9 
4.6  4-  0.6 
4.8  4-  1.8 
5.9  4-  0.8 
* Ratio of spleen weight (miLligram) to body weight (gram). Each number is the average 
of 30-48 animals 4- standard deviation. 
CBA mice with or without allogeneic thymus grafts (Table IV). This assay de- 
tects little reactivity in thymectomized irradiated  animals, but a  restoration of 
reactivity towards DBA  is observed after either C57BL  or A  thymus grafting. 
There  is  also  probably  some  restoration  of  reactivity  towards  A  mice  after 
C57BL thymus grafting, but the data are not conclusive. 
Hemolysins,  IIemagglutinins,  Hemolytic _Plaques, and Lymphocyte  Counts  in 
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data in Table V indicate a marked depression of both hemolysins and hemagglu- 
tinins  in  irradiated thymectomized mice  and  no  significant  restoration  after 
grafting  with  either  C57BL  or  A  thymuses.  (The  possible  exception  is  the 
several animals showing logs antibody titers of 8 or above after grafting.) Simi- 
larly, Table VI demonstrates that allogeneic thymus grafts incompatible at the 
H-2  locus  (A and  C57BL)  do not  restore the marked  depletion of hemolytic 
TABLE V 
Antibody Levels in Normal and Thymectomized CBA Mice with and without 
Thymus Grafts 
Thymee-  Thymus  Number of mice with logs antibody titers of 
tomy  graft  <3  3  4  5  6  7  8  9  10  >10 
Hemagglu- 
tinin 
Hemolysin 
--  --  3  3  0  3  4  16  39  28  14  6 
+  --  86  13  10  9  2  1  0  0  0  0 
+  C57BL  61  6  7  2  2  1  2  2  0  1 
+  A  24  3  4  1  1  1  1  0  0  0 
--  --  0  0  1  5  3  17  19  21  13  15 
+  --  60  19  12  4  3  2  0  0  0  1 
-b  C57BL  49  7  6  2  0  2  0  2  1  1 
+  A  17  3  3  0  1  0  1  0  1  1 
TABLE VI 
Hemolytic Plaque Response in Normal and Thymectomized CBA Mice with and 
without Thymus Homografts 
Thymec-  Thymus graft  Weight of thymus  Plaques/spleen  Standard deviation  Number of 
tomy  graft  animals 
mg 
--  --  38,400  4-  25,100  65 
+  --  1,500  ±  1,700  43 
+  C57BL  0  1,300  4-  1,600  59 
+  A  0  1,750  -4-  900  12 
+  AKR  59  4-  21  36,300  4- 31,800  22 
plaque-forming cells in the spleen of irradiated thymectomized mice. Thymus 
allograffs compatible at this locus (AKR) do restore such animals. It should be 
noted that while A  and C57BL  thymus grafts are identifiable only as minute 
scars on the kidney capsule (6 wk after thymus grafting), the H-2 compatible 
AKR  thymus allograft achieves a  weight comparable to that of a  thymus iso- 
graft (cf. reference 1, Table VI). 
There is also no evidence that C57BL thymus allografts restore the depressed 
lymphocyte  count  observed in  irradiated  thymectomized  CBA  mice.  10  wk 
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are: intact controls 5950  4-  2300;  thymectomy controls 3500  4-  1300; and 
thymectomy and C57BL thymus graft 3200 4- 1800. 
DISCUSSION 
The extensive immunological impairment of thymectomized irradiated adult 
CBA mice reported here is consistent with earlier observations (13, 14). Thus 
almost complete depression  of graft-vs.-host  activity and hemolytic plaque- 
forming ability of the spleen, hemolysin and hemagglutinin formation, and re- 
jection of skin homografts with minor (non-H-2) genetic incompatibility were 
demonstrated. However, lymphocyte counts were  but moderately depressed, 
and rejection time for skin with major (H-2) incompatibility was remarkably 
erratic with rejection times for most H-2 incompatible strains bridging the en- 
tire spectrum from normal rejection to permanent acceptance. (Strain A  skin 
was exceptional with permanent acceptance observed in thymectomized CBA 
mice and unusually long survival, for H-2 incompatible skin, in nonthymecto- 
mized animals.) This erratic rejection is reminiscent of the sporadic defect ob- 
served by Humphrey et  al.  (15)  in the ability of neonatally thymectornized 
mice to form various antibodies. These authors suggested that the presence or 
absence of response to a particular antigen was dependent upon whether or not 
seeding by the thymus had taken place in the newborn prior to thymectomy. 
We have no alternate explanation, but the proposal of Humphrey et al. seems 
unlikely  in  the  thymectomized irradiated  adult  mouse  in  which  complete 
thymectomy is easily performed and in which lethal irradiation obliterates the 
immunologically responsive cells. 
Our results with C57BL animals clarifies the inconsistency of earlier work on 
thymus function in this strain (14). It is clear that even after thymectomy and 
irradiation the C57BL mouse possesses  sufficient immunological reactivity to 
reject H-2 incompatible skin. Homografts compatible at the H-2 locus must be 
used to demonstrate convincingly thymus function in these animals. 
The central question we set out to answer in this investigation is whether a 
thymus homograft, despite its own rejection, is able to restore some or all of the 
immunological deficit of the thymectomized animal. Such restoration would pro- 
vide strong evidence for humoral mediation of thymus activity. 
Thymus homografts with H-2  compatibility do not answer  this  question, 
since such grafts are permanently accepted. Specific immunological tolerance 
can be demonstrated by survival of the thymus and of subsequent skin grafted 
from  the  same  strain.  Animals  restored  with  such  H-2  compatible  thymus 
grafts reject third party (H-2 compatible) skin grafts normally, and produce a 
normal  complement  of plaque-forming  spleen  cells  in  response  to  antigenic 
stimulation. The effectiveness of the H-2 compatible thymus graft is empha- 
sized by its ability to restore immune responsiveness when the thymus is grafted 
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This induction of specific tolerance to H-2 compatible skin homografts with thymus 
deserves comment.  Does this observation substantiate the view of Isakovic,  Smith, 
and Waksman  (16) that the thymus determines  immunological  tolerance?  In  this 
connection it would be important to establish whether the host tissues are populated 
by host lymphoid cells or by lymphoid cells of the genotype of the grafted thymus. 
Unfortunately, graft-vs.-host assays can not be applied to such instances where the in- 
compatibility lies outside  the H-2 locus (11), and the available chromosome marker 
study gives inconclusive results (3) : cells of both host and thymus donor genotype are 
found in lymph nodes and spleen. Thus it remains plausible that the tolerance induced 
by H-2 compatible thymus homografts represents a conventional tolerance mechanism 
in which developing lymphoid cells are presented with large amounts of histocompati- 
bility antigen. 
With the crucial H-2 incompatible thymus graft, interpretation of  results is 
complex because of overlapping of the H-2 alleles.  When the  thymus graft is 
followed by a skin graft of the same strain, accelerated skin rejection indicates 
that the thymus graft has immunized the recipient. Clearly, such  rejection of 
skin from the same strain as the thymus graft can be explained by immuniza- 
tion  without  any  restoration  of  immune  function.  When  third  party  skin 
grafts  are  applied the  results  are variable;  slight  to moderate restoration is 
seen  with  various  H-2  incompatible  strains.  Interpretation  of  experiments 
employing  CBA  recipients  is  ambiguous  because  all  available  thymus-skin 
combinations (including the ones used in these experiments) allow overlapping 
of part of the H-2 locus between thymus and skin donor. For example, all the 
strains studied, except the CBA, possess the 6 and  28 components of the H-2 
locus (17).  (Strain A recipients might permit this  immunogenetic difficulty to 
be circumvented). Thus, immunization cannot be excluded as an  explanation 
for restoration of third party skin graft rejection in CBA mice. The same argu- 
ments apply to restoration of graft-vs.-host activity since the histocompatibility 
relationships are the same. 
We have not observed the return of immune function other than rejection of 
H-2 incompatible skin and graft-vs.-host activity after grafting with H-2 in- 
compatible thymuses. There is no restoration of rejection of H-2  compatible 
skin  homografts,  or  of  hemolytic  plaque-forming  spleen  cells,  hemolysins, 
hemagglutinins,  or peripheral lymphocyte counts. This contrasts sharply with 
H-2 compatible thymus grafts, where survival of the graft is  associated with 
return of all these immune functions. We are therefore led to condude that the 
reconstitution observed with H-2 incompatible thymus grafts can be satisfac- 
torily ascribed to immunization by the thymus graft and does not necessarily 
indicate either immune restoration or humoral thymus function. It is evident 
from these experiments that thymus grafts placed beneath the kidney capsule 
serve as an effective means of immunization. The proliferating graft presents 
large amounts of histocompatibility antigen to the recipient's lymphoid system, 284  ALLOGENEIC  THYMUS  GRAFTS 
and depending upon the histocompatibility differences between host and graft, 
there results either tolerance or immunization. 
Thymus homografts have been used in several  earlier investigations. The 
study of Globerson and Feldman in mice (4) suffers from the same interpretive 
difficulty discussed above, i.e., since third party skin grafts were not employed 
the thymus graft may immunize rather than restore. Miller, Leuchars, Cross, 
and Dukor (2),  and later Leuchars, Cross,  and Dukor (3) have done studies  in 
mice similar to our own but less  extensive, with similar skin grafting results. 
However, these authors observed some restoration of hemolysin and hemagglu- 
tinin response, a discrepancy that is difficult to explain since some of the present 
work was repeated with express attention to their experimental details. Another 
pertinent  investigation  is  that  of Law  (5)  who  employed xenogeneic  (rat) 
thymus grafts in mice. Law reports restitution both  of third party  (mouse) 
skin graft rejection and of hemolysin and hemagglutinin formation. The results 
with rat thymus xenografts are also difficult to reconcile with the present work, 
but it should be pointed out that other workers (18) have been unable to restore 
immune function using the rat/mouse system. 
In balance then, the case for significant immunological restoration by thymus 
homografts (with H-2 incompatibility) remains to be established. Clearly, the 
present studies do not prove that such restoration does not occur, nor do they 
disprove the existence of a thymic hormone. However, this investigation does 
demonstrate  that  immunization of  the  recipient  by the  strategically placed 
thymus graft is a significant event and can satisfactorily explain the degree and 
parameters of immune recovery seen in the CBA mouse. 
SUMMARY 
Irradiated and thymectomized CBA mice are markedly depressed in several 
immunological parameters  (skin homograft rejection,  graft-vs.-host  activity 
and hemolytic plaque-forming cells of the spleen, hemolysin and hemagglutinin 
formation, and peripheral lymphocyte counts). In the present experiments the 
ability of homografts of neonatal thymus placed beneath the kidney capsule to 
restore immunological capacity of such animals was studied. 
Thymus homografts which share the same H-2 locus with the CBA mouse 
were permanently tolerated and immunological restoration was complete. Skin 
from the thymus donor was specifically retained, but third party skin with even 
minor (non-H-2) incompatibility was normally rejected and hemolytic plaque- 
forming cells of the spleen were restored. 
Thymus homografts which differ at the H-2 locus were promptly rejected and 
led to accelerated rejection of skin subsequently grafted from the thymus donor. 
With such H-2 incompatible thymus grafts, third party skin with minor histo- 
incompatibility was retained while there was slight to moderate restoration of 
rejection of skin with major (H-2) incompatibility. Graft-vs.-host activity was ALAN C.  AISENBERG  9-85 
restored,  but  there  was no return  of plaque-forming  spleen  cells,  hemolysins, 
hemagglutinins,  or peripheral  lymphocyte counts. 
In view of the cross-reactivity at the H-2 locus in CBA mice between thymus 
and third party skin donors,  it was felt that restoration  of skin rejection and 
graft-vs.-host activity could be adequately explained on the basis of immuniza- 
tion by the thymus graft and did not require  the postulation  of true immune 
restoration or a thymus hormone. 
I am grateful for the excellent technical assistance of Miss Susan Jolley and Miss Susan 
Brooks. 
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